Addictions Therapeutics Market Size, Growth and Forecast 2031
成瘾治疗市场规模预计在 2021 年为 74.3 亿美元,在 2023 年为 XX 百万美元,预计到 2031 年将达到 1449 万美元;预计到 2031 年的复合年增长率为 7.3%。各种治疗方法的持续推出可能仍是成瘾治疗市场的主要趋势。 CAGR of 7.3% till 2031. Consistent launch of various therapeutics are likely to remain key
成瘾治疗市场分析
领导人、执政当局和非政府组织 (NGO) 正在寻找新方法来提高人们的认识并对抗日益严重的药物成瘾现象。例如,化学品滥用委员会参与了各州和国家的各种活动,以提高人们对药物滥用、康复和预防的认识。
联合国毒品和犯罪问题办公室 (UNODC) 领导了一项全球性运动,旨在提高人们对非法毒品对社会和年轻人造成的主要挑战的认识。UNODC 在世界各地开展各种提高认识的活动,并邀请个人、私营部门、非营利组织和成员国组织针对非法贩运和药物滥用的机构外联计划。
此外,2023 年 8 月,印度发起了一项运动,以阻止青少年吸电子烟。该活动旨在推荐有效的解决方案,并寻求专家的帮助,以创建有影响力的沟通,强调吸电子烟的不利影响。此外,该活动旨在提高人们对印度和其他国家禁止吸电子烟的认识,解释此类措施背后的原因。
类似的宣传活动和政府为打击药物滥用、推广药物以摆脱各种瘾癖所做的努力可能会在预测期内推动市场增长。
成瘾治疗市场概览
全球成瘾治疗市场按地区细分为北美、欧洲、亚太、中东和非洲以及南美和中美。北美地区占有最大的市场份额,而亚太地区是增长最快的地区。北美市场的增长主要归因于新市场参与者的进入、各种产品的推出以及对一种或多种物质上瘾的人数不断增加。此外,亚太地区是全球成瘾治疗增长最快的市场。中国、印度和日本是市场增长的三大贡献者,推动因素包括大量的麻醉品消费、成瘾治疗仿制药的大量开发以及该地区本土参与者的崛起。此外,跨国制药公司的研发 (R&D) 投资也推动了市场的增长。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
成瘾治疗市场:
复合年增长率(2023 - 2031)7.3%- 2021 年市场规模
74.3 亿美元 - 2031年市场规模
144.9亿美元
市场动态
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
- 財政部
关键人物;主力;重要一员
- 个人 PLC
- 辉瑞公司
- 葛兰素史克公司
- 博士伦医疗公司
- 西普拉公司
- 奥雷克索公司
- 普渡制药公司
- 阿尔沃金
- 卡马鲁斯空军基地
- Hikma 制药公司
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 阿片类药物成瘾治疗
- 酒精成瘾治疗
- 尼古丁成瘾治疗
- 其他物质成瘾治疗
- 纳洛酮
- 纳曲酮
- 安非他酮
- 双硫仑
- 尼古丁替代产品
- 美沙酮
- 伐尼克兰
- 住院治疗中心
- 住院治疗中心
- 门诊治疗中心
- 医院药房
- 医药商店
- 其他的
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
成瘾治疗市场驱动因素和机遇
加强组织间合作以利于市场
成瘾治疗市场中有多家组织正在合作推动市场的增长。例如,2023 年 9 月,Click Therapeutics 与 Indivior 合作。此次合作旨在开发和商业化处方数字疗法,以治疗物质使用障碍,从阿片类药物使用障碍 (OUD) 开始。此次合作将通过一款名为 CT-102 的移动应用程序进行,旨在解决 OUD 的主要差距,例如获得高质量、个性化的心理社会治疗。
同样,2023 年 1 月,Pear Therapeutics 扩大了与门诊成瘾治疗诊所的合作。Spero Health 现在可以在五个州的 99 个地点使用 Pear 的 reSET 和 reSET-O 处方数字疗法,而之前仅在肯塔基州的 14 家诊所使用过这些疗法。因此,组织之间日益增长的伙伴关系推动了成瘾治疗市场的增长。
合同组织对研发的需求不断增长——一个机会
过去几年,制药行业外包服务迅速增长,这受到多种因素的推动,例如对止痛药的需求增长、API 复杂性增加以及降低开发成本的需求不断增长。大型制药公司正在外包研发活动,以提高药物开发过程的速度,同时降低开发和制造成本。
包括生产成瘾治疗药物的公司在内的各种制药公司都依赖合同研究组织 (CRO) 来最大限度地降低内部开发、制造能力和专业知识的高固定成本。新分子实体 (NME) 开发的复杂性日益增加,这产生了对利基能力的需求,制药公司更愿意将这种能力外包而不是内部开发。随着药品审批的增加(FDA 在 2023 年批准了 55 种 NME),强劲的临床开发和外包需求也在增加。各种生物技术公司都在利用 CRO 来扩大其潜在候选药物的渠道。通过外包降低药品制造成本可能会为市场参与者提供巨大的增长机会,从而最大限度地提高利润率并在充满活力的成瘾治疗市场中保持优势。
成瘾治疗市场报告细分分析
有助于成瘾治疗市场分析的关键部分是治疗类型、药物类型、治疗中心和分销渠道。
- 根据治疗类型,成瘾治疗市场分为尼古丁成瘾治疗、酒精成瘾治疗、阿片类药物成瘾治疗、其他物质成瘾治疗。尼古丁成瘾治疗领域在 2023 年占据了最大的市场份额。
- 根据药物类型,市场分为伐尼克兰、安非他酮、尼古丁替代产品、丁丙诺啡、纳曲酮、双硫仑等。伐尼克兰在 2023 年占据了最大的市场份额。
- 就治疗中心而言,市场分为门诊治疗中心、住院治疗中心和住院治疗中心。门诊治疗中心部分在 2023 年占据了市场主导地位。
成瘾治疗市场份额按地区分析
成瘾治疗市场报告的地理范围主要分为五个地区:北美洲、亚太地区、欧洲、中东和非洲、南美洲/南美洲和中美洲。
北美是成瘾治疗的最大市场,美国占有最大的市场份额,其次是加拿大。北美的增长特点是新市场参与者的进入、各种产品的推出以及对一种或多种物质上瘾的人数不断增加。美国市场参与者为成瘾治疗筹集资金。例如,2023 年 7 月,一家利用数字技术彻底改变成瘾治疗的公司 Affect Therapeutics 宣布,它在由专注于 TechBio 的投资公司 ARTIS Ventures 领投的 A 轮融资中筹集了 1600 万美元。筹集的资金将用于将公司的项目扩展到全国范围,并通过工程创新改进 Affect 应用程序。
成瘾治疗市场报告范围
报告属性 | 细节 |
---|---|
2021 年市场规模 | 74.3亿美元 |
2031 年市场规模 | 144.9亿美元 |
全球复合年增长率(2023 - 2031) | 7.3% |
历史数据 | 2021-2022 |
预测期 | 2023-2031 |
涵盖的领域 | 按治疗类型
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
成瘾治疗市场新闻和最新发展
成瘾治疗市场通过收集一级和二级研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下是成瘾治疗市场的发展列表:
- 2023 年 1 月,Hikma Pharmaceuticals PLC 以预充式注射器 (PFS) 形式推出盐酸纳洛酮注射液,USP,2mg/2mL。该药物用于已知或疑似阿片类药物过量的紧急治疗,是推出的第三款 PFS 产品。该注射液目前在美国有售。(来源:Hikma Pharmaceuticals PLC,2023 年)
- 2022 年 1 月,辉瑞与瑞典初创公司 Alex Therapeutics 合作,进军数字治疗领域。Alex Therapeutics 的 AI 平台将认知行为疗法 (CBT) 和接受与承诺疗法 (ACT) 与 AI 相结合,以提供个性化护理。双方合作的最初重点是创建用于治疗尼古丁成瘾的数字疗法,并将在德国市场开始努力。(来源:辉瑞,2022 年)
成瘾治疗市场报告覆盖范围和交付成果
“成瘾治疗市场规模和预测(2022-2030)”报告对市场进行了详细分析,涵盖以下领域:
- 范围内所有主要细分市场的全球、区域和国家层面的市场规模和预测
- 市场动态,如驱动因素、限制因素和关键机遇
- 未来主要趋势
- 详细的 PEST/波特五力分析和 SWOT 分析
- 全球和区域市场分析涵盖关键市场趋势、主要参与者、法规和最新市场发展
- 行业格局和竞争分析,涵盖市场集中度、热点图分析、知名参与者和最新发展
- 详细的公司简介
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
- Indivior PLC
- Pfizer, Inc.
- GlaxoSmithKline Plc
- Bausch Health Companies
- Cipla, Inc.
- Orexo AB
- Purdue Pharma L.P.
- Alvogen
- Camurus AB
- Hikma Pharmaceuticals Plc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.